ATEK vs. CRTX, OMCL, HSTM, MDRX, BZAI, AXAC, OACC, KVAC, PLMK, and MACI
Should you be buying Athena Technology Acquisition stock or one of its competitors? The main competitors of Athena Technology Acquisition include Cortexyme (CRTX), Omnicell (OMCL), HealthStream (HSTM), Veradigm (MDRX), Blaize (BZAI), AXIOS Sustainable Growth Acquisition (AXAC), Oaktree Acquisition Corp. III Life Sciences (OACC), Keen Vision Acquisition (KVAC), Plum Acquisition Corp, IV (PLMK), and Melar Acquisition Corp. I (MACI).
Athena Technology Acquisition vs.
Athena Technology Acquisition (NYSE:ATEK) and Cortexyme (NASDAQ:CRTX) are both small-cap companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, community ranking, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.
Athena Technology Acquisition has a beta of 0.37, suggesting that its share price is 63% less volatile than the S&P 500. Comparatively, Cortexyme has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500.
Athena Technology Acquisition received 478 more outperform votes than Cortexyme when rated by MarketBeat users. However, 64.44% of users gave Cortexyme an outperform vote while only 63.65% of users gave Athena Technology Acquisition an outperform vote.
In the previous week, Athena Technology Acquisition's average media sentiment score of 0.34 beat Cortexyme's score of 0.00 indicating that Athena Technology Acquisition is being referred to more favorably in the media.
17.3% of Athena Technology Acquisition shares are held by institutional investors. Comparatively, 63.2% of Cortexyme shares are held by institutional investors. 88.4% of Athena Technology Acquisition shares are held by company insiders. Comparatively, 27.9% of Cortexyme shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Athena Technology Acquisition's return on equity of 0.00% beat Cortexyme's return on equity.
Summary
Athena Technology Acquisition beats Cortexyme on 5 of the 8 factors compared between the two stocks.
Get Athena Technology Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Athena Technology Acquisition Competitors List
Related Companies and Tools
This page (NYSE:ATEK) was last updated on 4/3/2025 by MarketBeat.com Staff
Buy ATEK Stock Free ATEK Stock Alerts